Construction of Factory of Sinopharm Vaccines Helps Develop Business Zone Toward Nikola Tesla Airport
On September 26, he visited the works on the construction of the first factory for the production of the vaccines of the Chinese company Sinopharm in the settlement of Soko Salas. By March 2022, Serbia will get the first vaccine filling facility, which should have an annual capacity of around 30 million, and PCR tests will be produced here as well.
The factory is a joint investment of Serbia, China and the United Arab Emirates, is built by a turnkey principle and is a fully new investment that should secure sufficient quantities of the Sinopharm vaccine, not just for Serbia, but the region as well.
Naš izbor
Most Important News
06.04.2024. | Agriculture
Preconditions for Placement of Fresh Blueberries and Dried Plums in Chinese Market Secured
16.04.2024. | News
Jovan Ciric, Leasing Director Retail MPC Properties – MPC Echo symbolizes our desire for good ideas and innovative endeavors to spread freely and bring about positive changes
16.04.2024. | News
10.04.2024. | Finance, IT, Telecommunications, Tourism, Sports, Culture
Creative Industry – What This Serbian Economy Sector Worth EUR 2 Billion Encompasses
10.04.2024. | Finance, IT, Telecommunications, Tourism, Sports, Culture
17.04.2024. | Industry, Construction, Transport, Finance
Feka Automotive to build energy-efficient production facility – EBRD approves EUR 15 million
17.04.2024. | Industry, Construction, Transport, Finance
16.04.2024. | News
Economy Fair in Mostar opens – 26 companies from Serbia exhibiting
16.04.2024. | News
16.04.2024. | News
Polish chain Zabka to come to Serbia?
16.04.2024. | News